The aim of the present study was to develop polyamide 6 membrane blended wi
th gelatin and chondroitin sulfate using the phase precipitation method and
evaluate its in vitro biocompatibility. Morphology of membranes was studie
d by laser scanning confocal microscopy which allowed the nondestructive vi
sualization of internal bulk morphology of membranes. Membranes exhibited p
orous morphology with pores spanning across the membrane width with interco
nnections at various depths. Membranes showed adequate mechanical propertie
s with tensile strengths of 20.10 +/- 0.63 MPa, % strain of 3.01 +/-0.07. a
nd modulus of 1082.50 +/- 23.50 MPa. In vitro biocompatibility of membranes
by direct contact test did not show degenerative effects on NIH3T3 cells a
nd also its leach-out products (LOP), as determined by tetrazolium (MTT) an
d neutral red uptake (NRU) assay. Mouse peritoneal macrophage cultured in c
ontact with membranes and PTFE control showed comparable expression of acti
vation markers such as CD11b/CD18, CD45, CD14, and CD86 suggesting the memb
ranes non-activating nature. Membrane LOP did not induce excessive prolifer
ation of mouse splenocytes suggesting its non-antigenic nature. Preliminary
blood compatibility of membranes was observed with no detectable hemolysis
in static incubation assay. Taken collectively, the present data demonstra
te that polyamide 6 composite membranes are biocompatible and prospective c
andidates for tissue engineering applications.